Welcome to the new Gustave Roussy website
A new website designed to offer you a simpler, clearer, and more intuitive experience. Patients, caregivers, healthcare professionals, and donors: find information, news, and services more easily.
News
113 news
-
Treating Children Differently: The Birth of Paediatric Oncology at Gustave Roussy
Interpretation« Great advances in oncology » - Episode 4/4. In 1952, Dr Odile Schweisguth established Europe’s first paediatric oncology department at Gustave Roussy, at a time when the specialty was...
-
Research focus – Antibody Drug Conjugates, Nuclear Medicine… Four other Breakthroughs to Watch
InterpretationLast quarter also brought several other noteworthy developments. Researchers reported that delivering part of chemotherapy more precisely after surgery can help treat liver metastases...
-
Seeing Cancer in Its DNA: The Origins of Precision Medicine
Interpretation« Great advances in oncology » – Episode 3/4. Now considered indispensable in oncology, molecular profiling of tumours is one of the cornerstones of precision medicine. As early as 2011...
-
From Gene Discovery to Treatment: How LAG‑3 Opened a New Path in Immunotherapy
Interpretation“Great Advances in Oncology” – Episode 2/4. Discovered more than three decades ago at Gustave Roussy, the LAG‑3 gene is now at the heart of the development of new anticancer treatments...
-
Sun protection: the right habits to properly protect your skin
Public Health & PreventionSummer invites us outdoors — vacations, walks, long days in the sun. But enjoying the sunshine shouldn't mean forgetting the risks linked to ultraviolet (UV) radiation, the leading cause...
-
Five Gustave Roussy Scientists Appointed as Inserm Research Fellows
Awards & HonoursInserm – the French National Institute of Health and Medical Research – is the only French public research organisation entirely dedicated to human health. Each year, its new tenured...
-
The TNM Classification: An Invention Born at Gustave Roussy, Now the Universal Language of Cancer
Interpretation"Great Advances in Oncology” – Episode 1/4. Developed in the 1940s by Professor Pierre Denoix, the TNM classification has gradually become the tool that enables oncologists worldwide to...
-
Prof. Éric Vivier Receives the 2026 William B. Coley Award
The Cancer Research Institute (CRI) has awarded the William B. Coley Award for Distinguished Research in Basic and Tumor Immunology to Prof. Éric Vivier, holder of the Natural Killer (NK...
8 results per page